8x8, Inc.
$504.09M- Market cap
- $275.87M
- Debt
- +$321.48M
- Cash
- −$93.26M
Capital structure 46% equity / 54% debt · EV / Revenue 0.69x · EV / EBITDA 9.49x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $275.87M · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: EGHT stock price at discount vs OPK $1.91 current versus $10.15 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OPK's multiple
Implied fair value · at EGHT's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EGHT FY 2026 (ended Mar 31, 2026) · OPK FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 46% equity / 54% debt · EV / Revenue 0.69x · EV / EBITDA 9.49x
Capital structure 64% equity / 36% debt · EV / Revenue 2.53x
OPK carries the larger enterprise value at $1.53B against $504.09M; EGHT trades on the lower EV / Revenue multiple (0.69x vs 2.53x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
8x8, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.19x
0.54x
Net debt / EBITDA
Leverage against operating earnings
4.30x
-3.03x
Cash and equivalents
Liquid reserves on the balance sheet
$93.26M
$364.41M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Zoom Communications, Inc.
EGHT vs ZM
CISCO SYSTEMS, INC.
EGHT vs CSCO
TWILIO INC
EGHT vs TWLO
RingCentral, Inc.
EGHT vs RNG
Five9, Inc.
EGHT vs FIVN
AMARIN CORP PLC\UK
EGHT vs AMRN
Sarepta Therapeutics, Inc.
EGHT vs SRPT
Amphastar Pharmaceuticals, Inc.
EGHT vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
EGHT vs SUPN
Harmony Biosciences Holdings, Inc.
EGHT vs HRMY
$321.48M
$687.93M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.